Renaissance Technologies’s Mereo BioPharma MREO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.01M Buy
1,480,471
+130,000
+10% +$352K 0.01% 1659
2025
Q1
$3.04M Buy
1,350,471
+161,000
+14% +$362K ﹤0.01% 1732
2024
Q4
$4.16M Sell
1,189,471
-115,900
-9% -$406K 0.01% 1565
2024
Q3
$5.37M Sell
1,305,371
-456,632
-26% -$1.88M 0.01% 1404
2024
Q2
$6.34M Buy
1,762,003
+89,694
+5% +$323K 0.01% 1165
2024
Q1
$5.52M Sell
1,672,309
-125,700
-7% -$415K 0.01% 1355
2023
Q4
$4.15M Buy
1,798,009
+70,439
+4% +$163K 0.01% 1468
2023
Q3
$2.23M Sell
1,727,570
-51,202
-3% -$66.1K ﹤0.01% 1795
2023
Q2
$2.35M Buy
1,778,772
+862,863
+94% +$1.14M ﹤0.01% 1891
2023
Q1
$647K Sell
915,909
-341,460
-27% -$241K ﹤0.01% 2734
2022
Q4
$943K Buy
1,257,369
+23,755
+2% +$17.8K ﹤0.01% 2570
2022
Q3
$1.06M Buy
1,233,614
+624,705
+103% +$538K ﹤0.01% 2460
2022
Q2
$682K Buy
608,909
+325,109
+115% +$364K ﹤0.01% 2963
2022
Q1
$318K Buy
283,800
+63,200
+29% +$70.8K ﹤0.01% 3446
2021
Q4
$353K Sell
220,600
-178,300
-45% -$285K ﹤0.01% 3267
2021
Q3
$965K Buy
398,900
+113,800
+40% +$275K ﹤0.01% 2573
2021
Q2
$904K Buy
285,100
+17,900
+7% +$56.8K ﹤0.01% 2717
2021
Q1
$900K Sell
267,200
-92,000
-26% -$310K ﹤0.01% 2656
2020
Q4
$1.29M Buy
359,200
+338,000
+1,594% +$1.21M ﹤0.01% 2374
2020
Q3
$56K Sell
21,200
-29,200
-58% -$77.1K ﹤0.01% 3265
2020
Q2
$154K Buy
+50,400
New +$154K ﹤0.01% 3207
2020
Q1
Sell
-126,323
Closed -$414K 3664
2019
Q4
$414K Sell
126,323
-39,800
-24% -$130K ﹤0.01% 2964
2019
Q3
$495K Sell
166,123
-29,800
-15% -$88.8K ﹤0.01% 2872
2019
Q2
$494K Buy
+195,923
New +$494K ﹤0.01% 3005